Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors – Contact Levi & Korsinsky
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. (NASDAQ: NTLA) by Levi & Korsinsky, LLP, seeking recovery for investors.
February 27, 2025 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit filed by Levi & Korsinsky, LLP, which could impact investor confidence and the company's stock price.
The filing of a class action lawsuit against Intellia Therapeutics is likely to negatively impact investor sentiment and could lead to a decrease in the stock price in the short term. Legal actions often create uncertainty and can result in financial liabilities for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100